Effectiveness of Calcium and Vitamin D, With and Without Collagen Peptide, in Enhancing Bone Mineral Density on Postmenopausal Women With Osteopenia
NCT06464718 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2024-06-24
Summary
Osteopenia is characterized by bone mineral density (BMD) being lower than normal but not reaching the osteoporosis threshold, poses a serious problem for women after menopause. Osteopenia is a precursor to osteoporosis that is associated with increased risk of fractures, morbidity, and mortality. Using strategies to improve or maintain bone density is important for preventing osteoporosis and its associated complications. The combination of collagen peptide (CP) with calcium and vitamin D supplementation may provide several ways to improve bone health. This study aims to provide preliminary evidence of the effectiveness of traditional medicine in improving bone health through the effectiveness of CP.
Conditions
- Osteopenia
Interventions
- DRUG
-
Fortibone
Participants were given daily sachet containing 5g of Bio active collagen peptides (Fortibone). Electrolyte mix containing 500 mg calcium as calcium lactate, 4 MCg calcitriol and selenised yeast rich in vitamin D3 (400IU) (Colabone®, Vivapharm SA).
- DRUG
-
Chewable Tablet
calcium compound containing 25 g calcium carbonate (500mg elemental calcium) and vitamin D3 400IU taken daily
Sponsors & Collaborators
-
Frontier Medical and Dental College, Abbotabad
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-20
- Primary Completion
- 2022-12-10
- Completion
- 2023-01-16
Countries
- Pakistan
More Related Trials
-
A Dose-Ranging Study of MK-5442 in Postmenopausal Women With Osteoporosis (MK-5442-001)
NCT00960934 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
NCT00092079 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)
NCT00112437 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)
NCT00398606 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)
NCT00165607 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin K and Bone Turnover in Postmenopausal Women
NCT00062595 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)
NCT00620113 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
NCT00092066 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamin K Supplementation in Post-Menopausal Osteopenia
NCT00150969 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of OsteoBor in Postmenopausal Osteoporosis
NCT06809816 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women
NCT00693667 ·Status: COMPLETED ·Phase: PHASE2
-
Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss
NCT04609189 ·Status: COMPLETED ·Phase: PHASE4
-
Melatonin-Micronutrients for Osteopenia Treatment Study
NCT01870115 ·Status: COMPLETED ·Phase: PHASE1
-
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
NCT07242612 ·Status: RECRUITING ·Phase: NA
-
Novel Combination Therapy for Osteoporosis in Men
NCT03994172 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)
NCT00529373 ·Status: TERMINATED ·Phase: PHASE3
-
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
NCT00086619 ·Status: COMPLETED ·Phase: PHASE2
-
Calcium Supplementation in Postmenopausal Women
NCT00172172 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)
NCT00713258 ·Status: TERMINATED ·Phase: PHASE4
-
Osteoporosis Prevention With Low Dose Alendronate
NCT00463268 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass
NCT00078026 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
NCT01753856 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Teriparatide Therapy for Japanese
NCT01956461 ·Status: UNKNOWN
-
Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
NCT01760798 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia
NCT02731820 ·Status: COMPLETED ·Phase: NA